Prognostic value of body composition and nutritional assessment in recurrent/metastatic squamous cell carcinoma of head and neck (R/M SCCHN) treated with immunotherapy (IO)

被引：0
|
作者：
Vidales Sepulveda, Z. [1 ]
Choulli, M. [2 ]
Fabrego, S. [2 ]
Pallares, N. [3 ]
Santos, N. [3 ]
Llop Serna, S. [1 ]
Brenes Castro, J. [1 ]
Plana Serrahima, M. [4 ]
Juarez Lozano, C. M. [5 ]
Brunet, A. [6 ]
Melero, M. [7 ]
Bermejo, O. [8 ]
Vilajosana, E. [1 ,9 ]
Godino, C. [10 ]
Oliva, M. [11 ]
Arribas, L. [12 ]
机构：
[1] ICO Inst Catala Oncol Hosp Hosp Duran I Reynals, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[2] ICO Inst Catala Oncol Hosp Hosp Duran I Reynals, Nutr Dept, Lhospitalet De Llobregat, Spain
[3] IDIBELL Bellvitge Biomed Res Inst, Biostat Unit, Lhospitalet De Llobregat, Spain
[4] ICO Inst Catala Oncol Hosp Hosp Duran I Reynals, Med Oncol Dept, Barcelona, Spain
[5] Inst Catala Oncol Hosp Duran I Reynals ICO LHospi, Radiat Oncol, Barcelona, Spain
[6] Hosp Univ Bellvitge, Otolaryngol Dept, Lhospitalet De Llobregat, Spain
[7] Hosp Univ Bellvitge, Oral & Maxillofacial Surg Dept, Lhospitalet De Llobregat, Spain
[8] Hosp Univ Bellvitge, Plast Surg Dept, Lhospitalet De Llobregat, Spain
[9] ICO Inst Catala Oncol Hosp Hosp Duran I Reynals, Med Oncol Dept, Lhospitalet De Llobregat, Spain
[10] Inst Catala Oncol Hosp Duran I Reynals ICO LHospi, Med Oncol Dept, Barcelona, Spain
[11] Inst Catala Oncol Hosp Duran I Reynals ICO LHospi, Moliva Iconcol Net, Barcelona, Spain
[12] Inst Catala Oncol, Clin Nutr Unit, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2072
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
928P
引用
收藏
页码：S585 / S586
页数：2
相关论文
共 50 条
  • [31] Next generation sequencing (NGS) helps predict response to immunotherapy (IO) in recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients (pts)
    Mirallas, O.
    Marmolejo Castaneda, D. H.
    Illescas, D. G.
    Gomez-Puerto, D.
    Berche, R.
    Calvo, A. H.
    Vieito Villar, M.
    Lorini, L.
    Navarro, V.
    Assaf Pastrana, J. D.
    Saavedra, O.
    Alonso, G.
    Aguilar Izquierdo, S.
    Bescos, C.
    Lorente, J.
    Giralt, J.
    Dienstmann, R.
    Garralda, E.
    Felip, E.
    Brana, I.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S856 - S857
  • [32] Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients
    Hernando-Calvo, Alberto
    Mirallas, Oriol
    Marmolejo, David
    Saavedra, Omar
    Vieito, Maria
    Pastrana, Juan David Assaf
    Aguilar, Susana
    Bescos, Coro
    Lorente, Juan
    Giralt, Jordi
    Benavente, Sergi
    Temprana-Salvador, Jordi
    Alberola, Margarita
    Dienstmann, Rodrigo
    Garralda, Elena
    Felip, Enriqueta
    Villacampa, Guillermo
    Brana, Irene
    ORAL ONCOLOGY, 2023, 140
  • [33] Phase II trial of sunitinib in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Choong, N. W.
    Cohen, E. E.
    Kozloff, M. F.
    Taber, D.
    Wade, J. L., III
    Hu, S.
    Ivy, S. P.
    Nichols, K.
    Dekker, A.
    Vokes, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [34] Radiomic features in recurrent/metastatic platinum refractory head and neck squamous cell carcinoma treated with immunotherapy.
    Anile, Giuseppe
    Bettinelli, Andrea
    Paiusco, Marta
    De Conti, Giorgio
    Gottardi, Chiara
    Conte, Pierfranco
    Ghi, Maria Grazia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] The prognostic value of lymphatic metastatic size in head and neck squamous cell carcinoma
    Xie, Wenqian
    Lin, Peiliang
    Li, Zhijuan
    Wan, Huan
    Liang, Faya
    Fan, Jianming
    Deng, Lanlan
    Huang, Xiaoming
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (01) : 387 - 395
  • [36] The prognostic value of lymphatic metastatic size in head and neck squamous cell carcinoma
    Wenqian Xie
    Peiliang Lin
    Zhijuan Li
    Huan Wan
    Faya Liang
    Jianming Fan
    Lanlan Deng
    Xiaoming Huang
    European Archives of Oto-Rhino-Laryngology, 2024, 281 : 387 - 395
  • [37] M-VAC chemotherapy and GM-CSF in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Degardin, M
    Cappelaere, P
    Caty, A
    Lefebvre, JL
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 438 - 438
  • [38] Palliative chemotherapy (CT) with or without cetuximab (CTX) in recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): An Indian retrospective analysis
    Bahl, A.
    Choudhary, P.
    Bhatia, K.
    Singhla, S.
    Shrivastava, G.
    Bal, J.
    Anand, A. K.
    Chaturvedi, H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [39] The effect of opioids on the efficacy of immunotherapy in recurrent/ metastatic squamous cell carcinoma of the head and neck
    Scheff, Nicole N.
    Nilsen, Marci L.
    Li, Jinhong
    Harris, Alexandria L.
    Acharya, Rajesh
    Swartz, Andrew
    Hsieh, Ronan W.
    Anderson, Jennifer L.
    Ferris, Robert L.
    V. Menk, Ashley
    Delgoffe, Greg M.
    Zandberg, Dan P.
    ORAL ONCOLOGY, 2023, 140
  • [40] Alpelisib and Immunotherapy: A Promising Combination for Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
    Suleiman, Riham
    McGarrah, Patrick
    Baral, Binav
    Owen, Dawn
    Aguilera, Jesus Vera
    Halfdanarson, Thor R.
    Price, Katharine A.
    Bayne, Harry E. Fuentes
    CANCER REPORTS, 2024, 7 (10)
12345